Home › News and Press › Page 5

News and Press releases

View all News Press releases

New studies show OXC-101 further improves conventional chemotherapy treatment in Acute Myelom Leukemia (AML)

March 23, 2022 · News and Press

Oxcia reports positive interim data from clinical phase I study in advanced solid cancers

January 17, 2022 · News and Press

Oxcia contracts Patheon for manufacturing and further strengthens the organization

· News and Press

Affärsjurist till Oxcia AB

September 22, 2021 · News and Press

New studies show potential role for Karonudib also in autoimmune diseases

September 7, 2021 · News and Press

Oxcia employs a Chief Medical Officer (CMO)

August 23, 2021 · News and Press

Kommunike från årsstämma

July 13, 2021 · News and Press

Kallelse till ordinarie bolagsstämma i Oxcia AB

May 31, 2021 · News and Press

Chief Medical Officer (CMO) till Oxcia AB

May 20, 2021 · News and Press

Kallelse till Extra Bolagsstämma i Oxcia AB

February 4, 2021 · News and Press

New tablet formulation of karonudib is introduced in the clinical trials

November 18, 2020 · News and Press

Oxcia stärker styrelsen med Thomas Helleday, Eva Sjökvist Saers och Jan Benjaminson

July 11, 2020 · News and Press

Search